Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial-Reference-Cited by-同舟云学术

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

Published:2014-11 Issue:11 Volume:2 Page:875-884
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Gadelha Mônica R,Bronstein Marcello D,Brue Thierry,Coculescu Mihail,Fleseriu Maria,Guitelman Mirtha,Pronin Vyacheslav,Raverot Gérald,Shimon Ilan,Lievre Kayo Kodama,Fleck Juergen,Aout Mounir,Pedroncelli Alberto M,Colao Annamaria

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Medical progress: acromegaly;Melmed;N Engl J Med,2006

2. Expert consensus document: a consensus on the medical treatment of acromegaly;Giustina;Nat Rev Endocrinol,2014

3. Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly;Chanson;Clin Endocrinol (Oxf),2008

4. Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study;Colao;Clin Endocrinol (Oxf),2009

5. Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension;Melmed;Pituitary,2010

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of acromegaly – When the tumor size matters: A narrative review;Growth Hormone & IGF Research;2024-10

2. Efficacy and Safety of Pasireotide Treatment in Acromegaly: A Systematic Review and Single Arm Meta-Analysis;2024-08-27

3. Is diabetes with acromegaly for life?;Pituitary;2024-08-01

4. Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies;Diabetes Therapy;2024-07-31

5. An Overview of Cardiovascular Risk in Pituitary Disorders;Medicina;2024-07-30